COLTENE HOLDING AG

CLTN

Equity

ISIN CH0025343259 / Valor 2534325

SIX Swiss Exchange (2026-10-06)

CHF 46.25+1.65%

COLTENE HOLDING AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Coltène Holding AG is a Swiss-based manufacturer and distributor of dental consumables, instruments and small equipment serving dental practices and laboratories worldwide. The company supplies materials and tools used across restorative dentistry, endodontics, prosthetics and infection prevention, combining product development, manufacturing and an international sales and distribution network to reach clinicians and distributors in multiple markets. Organized as a publicly traded group on the SIX Swiss Exchange, Coltène generates recurring revenue from high-volume consumables and incremental sales of associated devices and disposables while expanding its portfolio through product development and targeted acquisitions.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue

Net sales CHF 118.1m (H1 2024: CHF 127.5m; -7.4% reported). On a constant‑currency basis the decline was -4.9%; currency movements (weaker USD, EUR, CAD) reduced revenue by ~2.5 percentage points. COLTENE cites cautious customer demand and temporary order delays from dealer-term renegotiations.

Profitability

Gross margin held near prior year at 66.4% (H1 2024: 66.6%) thanks to procurement savings. EBIT was CHF 7.527m (margin 6.4% vs 10.2% in H1 2024). Net profit fell to CHF 4.265m (down 59.1% y/y), reflecting lower volumes partly offset by strict cost control.

Cash flow and balance sheet

Free cash flow turned negative at CHF -0.3m (H1 2024: CHF 13.8m) due to lower earnings and proactive inventory build-up in North America and Europe. Operating cash flow CHF 1.588m (vs CHF 16.471m). Net debt reported as -CHF 34.6m (i.e., net cash position), improving versus -CHF 24.1m a year earlier; equity CHF 90.4m (down 9.6%).

Segments & regions

All product areas were affected: Infection Control down 2.0% (cc), Dental Preservation & Improvement down 4.8% (cc), Treatment Auxiliaries down 7.4% (cc). North America (48.3% of sales) fell ~4.1% (cc); EMEA down 6.8% (cc) impacted by dealer changes and Middle East; Asia slight share gain to 11.0% but -3.5% local; Latin America -3.0% (cc).

Operational actions and product launches

COLTENE cites optimisation of dealer management, procurement savings and a streamlined cost structure. The company launched the HYDRIM 112W washer (soft launch in Canada) aimed at reducing manual work and resource use, positioning for growth in automated instrument washers.

Outlook and guidance

COLTENE expects a significantly better H2 2025 but limits visibility due to geopolitics and therefore provides no revenue guidance. It now expects a 2025 EBIT margin around 10% (previously ~11%). Medium‑term targets remain 3–5% organic growth and 13–15% EBIT margin, assuming geopolitical stabilisation.

Summarized from source with an LLMView Source

Key figures

6.20%1Y

-29.8%3Y

-58.3%5Y

Performance

32.1%1Y

32.0%3Y

32.8%5Y

Volatility